logo BDSP

Base documentaire

  1. Fulltext. Estrogen replacement therapy and prognosis after first myocardial infarction.

    Article - En anglais


    The effects of estrogen replacement therapy on prognosis in women with established coronary disease remain uncertain.

    The authors conducted a retrospective cohort study of 726 women (mean age, 66.2 years) who survived first myocardial infarction to hospital discharge from 1980 through 1991, while enrolled at Group Health Cooperative of Puget Sound in western Washington State.

    Estrogen replacement therapy after myocardial infarction (122 women) was ascertained from computerized pharmacy records.

    Reinfarctions (n=135) and deaths (n=183) through 1993 were identified, and relative risks were calculated.

    The relative risk for reinfarction associated with current estrogen replacement therapy after myocardial infarction, adjusting for age and time since infarction, was 0.64 (95% confidence interval (Cl) 0.32-1.30), and that for past estrogen replacement therapy was 0.90 (95% CI 0.62-1.31).

    The relative risk for all-cause mortality associated with current estrogen replacement therapy was 0.50 (95% Cl 0.25-1.00), and that for past estrogen replacement therapy was 0.79 (95% Cl 0.56-1.09).

    While estrogen users were less likely than nonusers to have a history of diabetes or congestive heart failure, adjustment for these and additional prognostic factors altered risk estimates only slightly.

    Estrogen replacement therapy after first myocardial infarction was not associated with increased risk of reinfarction or mortality. (...)

    Mots-clés Pascal : Infarctus, Myocarde, Oestrogène, Traitement substitutif, Pronostic, Activité biologique, Femme, Homme, Etude cohorte, Rétrospective, Etats Unis, Amérique du Nord, Amérique, Appareil circulatoire pathologie, Cardiopathie coronaire, Myocarde pathologie, Hormone

    Mots-clés Pascal anglais : Infarct, Myocardium, Estrogen, Replacement therapy, Prognosis, Biological activity, Woman, Human, Cohort study, Retrospective, United States, North America, America, Cardiovascular disease, Coronary heart disease, Myocardial disease, Hormone

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0172445

    Code Inist : 002B12A03. Création : 21/05/1997.